Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

nues 7,673 12,018 16,995 25,173

492,715 447,212 935,934 884,246

COSTS AND EXPENSES:

Cost of sales 101,318 83,166 191,234 169,712

Research and development 80,409 96,593 161,844 180,551

Selling, general and

administrative 209,900 189,052 408,884 341,506

Settlement reserve - 56,000 - 56,000

Restructuring charges 1,565 - 5,476 -

In-process research and

development - - 10,000 -

393,192 424,811 777,438 747,769

INCOME FROM OPERATIONS 99,523 22,401 158,496 136,477

OTHER INCOME (EXPENSE):

Interest income 4,912 8,041 11,513 14,617

Interest expense (7,872) (5,017) (16,866) (9,612)

Gain on sale of investment - 5,791 - 5,791

Other income (expense), net (1,543) (1,502) 3,772 1,254

(4,503) 7,313 (1,581) 12,050

INCOME BEFORE INCOME TAXES 95,020 29,714 156,915 148,527

INCOME TAX EXPENSE 34,952 34,022 57,996 77,650

NET INCOME (LOSS) $ 60,068 $ (4,308) $ 98,919 $ 70,877

BASIC INCOME (LOSS)

PER COMMON SHARE $0.89 $(0.06) $1.46 $1.07

DILUTED INCOME (LOSS)

PER COMMON SHARE $0.80 $(0.06) $1.33 $0.90

WEIGHTED AVERAGE NUMBER OF

COMMON SHARES OUTSTANDING 67,777 66,445 67,721 66,127

WEIGHTED AVERAGE NUMBER

OF COMMON SHARES

OUTSTANDING-ASSUMING DILUTION 74,852 66,445 74,569 78,656

CEPHALON, INC. AND SUBSIDIARIES


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 “This kit has ... to screen from 0 to 150 ppb,” said Mark Tess, ... a significant benefit to plant owners and USDA-GIPSA inspection agencies ... other commodities. Testing can take place in a matter of ... can the plant test the feed and grain before accepting ...
(Date:8/28/2014)... spintronics, an electronic which is not only based ... their spin and the spin-related magnetism. Spin-charge converters ... and vice versa. Recently, the research group of ... at Johannes Gutenberg University Mainz in collaboration with ... for the first time realised a new, efficient ...
(Date:8/28/2014)... August 28, 2014 The ability for ... culture that will allow individuals to perform at the ... important for employers looking to compete in this post–recession ... embracing this trend, as the sector increasingly focuses on ... company, which will have real results on the organization's ...
(Date:8/28/2014)... ATLANTA , Aug. 28, 2014   SunTrust ... of three industry veterans to its equity research ... "Our ongoing expansion in equity research demonstrates ... with unique insights to enhance their investment decision ... Equities at STRH.  "We continue to make significant ...
Breaking Biology Technology:A new, tunable device for spintronics 2A new, tunable device for spintronics 3Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
... - TomoTherapy, Inc. , a developer of radiation therapy ... of Hope , a national medical center based in Duarte, ... bone marrow transplantation, is among a growing number of treatment ... With the technology, clinicians are able to produce a 3-dimensional ...
... - In a move to increase its international presence, ... Microsoft large account reseller, will merge with the Swiss ... will take effect July 1, will make Software ONE ... companies worldwide, according to Michael Quinn, the company's chief ...
... Milwaukee, Wis. - Metavante Corp ., the ... Ilsley Corp ., is in the final stages of ... of corporate payment processing software. , ,VICOR is being ... commercial treasury solutions to its client financial institutions so ...
Cached Biology Technology:Software ONE merges with Swiss firm 2
(Date:8/29/2014)... SAN ANTONIO (Aug. 29, 2014) Scientists at the ... the School of Medicine at the UT Health Science ... longevity in the tissues of the longest-lived rodent, the ... factor in the cells of naked mole rats protects ... disposer for damaged and obsolete proteins. , The factor ...
(Date:8/29/2014)... To understand how the repeated climatic shifts over ... patterns of genetic diversity, a team of researchers ... Dr. Ana Carnaval developed a new biodiversity metric ... to which the genetic variation within species is ... assistant professor of biology, and 14 other researchers ...
(Date:8/29/2014)... German . ... considered the oldest form of communication. Acting as messenger ... the sexual attraction between males and females. Fish rely ... reproductive behavior in males and females. Scientists at the ... in Faro, Portugal, and at the Max Planck Institute ...
Breaking Biology News(10 mins):Factor in naked mole rat's cells enhances protein integrity 2CCNY team defines new biodiversity metric 2Ready for mating at the right time 2Ready for mating at the right time 3
... 2010) In three monthly injections, researchers transplanted neurally-committed, ... nanoparticles (SPIO) into the lateral cerebral ventricle of a ... injury. The study, published in the current issue ... available online at http://www.ingentaconnect.com/content/cog/cm , found through ...
... revealed multiple genetic discoveries that may permit easier diagnosis and ... breast and kidney cancer. The research, which could ... the Dec. 22 issue of the Journal of the ... Eng, M.D., Ph.D, Chair of the Genomic Medicine Institute at ...
... your water source has hexavalent chromium is to check ... quality report, said NJIT Professor Taha Marhaba, a civil/environmental ... able to provide such a report upon request. ... be available. "In general, hexavalent chromium can be ...
Cached Biology News:Cord blood cell transplantation provides improvement for severely brain-injured child 2Researchers discover genetic predisposition for breast, kidney cancers 2Removal of hexavalent chromium from your drinking water 2Removal of hexavalent chromium from your drinking water 3
... complete components including positive and negative control ... in cultured cells and tissue sections. The ... greater sensitivity than biotinylated or digoxigenylated methods. ... The kit works well with GFP transfected ...
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... ion chromatography system . The sensitive conductivity ... to 5000S, houses the measuring cell in a ... is available. Data processing is provided by ... is by the high pressure CE 4100 dual ...
The Mu-End™ Protein Truncation Kit provides a convenient method for generating a library of N-terminal and C-terminal protein deletions that can be expressed in E. coli....
Biology Products: